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1. Introduction 
Gastric cancer (GC) has high incidence (> 1.000.000 new cases/year) and mortality rate in 
several countries and is still one of the most frequent and lethal (> 600.000 dead/year) 
neoplasia with an average survival of five years (less than 20%) (Pisani et al., 1990; Lands et 
al., 1998). It is already well known that infection of gastric antrum mucosal with the 
bacterium Helicobacter pylori is the cause of the chronic inflammation that leads to intestinal-
type gastric cancer in the majority of the cases. The H. pylori infection is widespread but only 
a small number of the total population of infected individuals might eventually develop 
adenocarcinoma (around 3/10,000 individuals per year or 2.1% for lifetime infection) 
(Correa & Piazuelo, 2008). Risk factors influencing the outcome of H. pylori–associated 
pathology include bacterial cytotoxic heterogeneity, diet, and geographic differences. The 
phenomenon of decreased gastric cancer incidence in Africa compared with other regions 
where H. pylori is endemic (Holcombe, 1992) is probably due to the different diet of these 
populations compared to the western countries. This discrepancy has been partially 
attributed to helminth co-infection that likely modifies the characteristic proinflammatory 
type 1 T-helper 1 cell response, to a T-helper 2–predominant response (Whary et al., 2005), 
typified by the release of non-inflammatory cytokines and reduced incidence of H. pylori–
associated glandular atrophy, an early marker of cancer development. The identification of 
novel genes regulated by H. pylori in vivo, particularly those contributing to these early 
stages of gastric cancer, would facilitate improved understanding of the differential 
susceptibility to this pathogen. The different susceptibility among individuals to H. pylori 
infection is still not yet defined. Some works, however, suggested that the polymorphisms 
in host genetic factors like the proinflammatory cytokines interleukin-1, interleukin-8, and 
tumor necrosis factor may play a relevant role (El-Omar et al., 2003). 
The evolution of intestinal tumours is characterized by a progression of several sequential 
steps that starts with gastritis and then progresses to mucosal atrophy (atrophic gastritis), 
intestinal metaplasia, dysplasia and carcinoma with subsequent metastatic dissemination 
(Correa, 1992, 1995). The diffuse-type has instead a poorer prognosis and develops through 
unknown genetic and morphological events from normal gastric epithelium. No preceding 
steps have been identified in the pathogenesis of diffuse carcinoma other than the chronic 
gastritis. The pathogenesis of gastric cancer remains poorly understood although it is 
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evident that several environmental factors, such as H. pylori infection can be one of the 
causes leading to this disease. In fact, the risk to develop gastric cancer is increased in 
patients with H. pylori infections probably as the result of a combination of genetic and 
environmental factors in which the infection by H. pylori is of particular relevance, especially 
when the inflammation involves the gastric body region with respect to the antrum (Correa, 
1995; Goldstone et al., 1996; Nabewera & Logan, 1999). Generally, this condition is 
associated to different degrees of atrophy and alterations of the secretor function that, in the 
long term, became associated to gastric carcinoma (Forman et al., 1991; Parsonnet et al., 
1997; Watanabe et al., 1998). 
Diffuse adenocarcinoma shows an increased propensity for intra and transmural spread and 
is therefore associated with a poorer prognosis. Unfortunately, the histological classification 
of an individual gastric adenocarcinoma is not clear-cut with a tumour often comprising a 
mixture of intestinal and diffuse tissue types. Under these considerations, we think that 
there is an urgent necessity to dispose of an efficient tool for the detection of early stage 
gastric cancer like the identification of highly sensitive and specific biomarkers that will aid 
disease diagnosis and ensure early clinical intervention, thereby preventing mortality and 
reducing morbidity (Boussioutas & Taupin, 2001). Since most of GC (around 73%) is 
developed at antrum/pylorus, proteins secreted by antrum/pylorus mucosa might play a 
critical role in maintaining normal gastric mucosa structure and function. 
2. Expression of gastrokine 1 in normal and malignant tissues 
From a comparative proteomic analysis of human specimens of gastric mucosa from 
patients with and without H. pylori infection, we have shown the differential expression of 
several up- and down-regulated proteins (Rippa et al., 2007). One of these proteins, 
gastrokine 1 (GKN1), a novel stomach-specific protein also known as 18 kDa antrum 
mucosa protein (AMP-18 or foveolin) (Oien et al., 2004), was highly expressed in normal 
tissues and markedly down-regulated in samples derived from H. pylori infected patients 
(Nardone et al, 2007). To elucidate the biological function of GKN1, we have characterized 
its expression in normal and malignant gastric tissues also by immunohistochemical 
technique. The etiology of most gastric cancers is multifactorial and the pathogenesis is 
believed to involve a multi-step process in which the normal gastric epithelium evolves 
through intermediate pre-malignant lesions (intestinal metaplasia and dysplasia) leading to 
adenocarcinoma. These investigations were based on the hypothesis that GKN1 expression 
in pre-malignant gastric tissues and in gastric carcinomas is altered in terms of quantity 
(reduced amount or complete absence of the protein), quality (altered protein size), and 
distribution (abnormal cell-type and/or subcellular localization) compared to normal gastric 
tissues.  
2.1 The gastrokine family 
GKN1 belongs to a family of genes encoding stomach-specific secreted proteins consisting of 
3 known members: gastrokine 1 (GKN1) (Martin et al., 2003), gastrokine 2 (GKN2) (Du et al., 
2003), and gastrokine 3 (GKN3) (Menheniott et al., 2010). Although their mode of action 
remains unclear, the recent demonstration of a GKN2/trefoil factor (TFF1) heterodimer in 
gastric mucus suggests that gastrokines may regulate the extracellular function of TFFs 
(Westley et al., 2005). 
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2.2 Gastrokine 1 
GKN1 (also named as AMP18), a member of BRICHOS superfamily, is secreted by antrum 
mucosa (Oien et al., 2004). GKN1 gene of about 6 kb was reported to be located at 2p13 and 
contains 6 exons (Martin et al., 2003). Bioinformatics analysis suggested the secretory signal 
peptide with 20-amino acids presented at the N-terminal and the processed protein 
consisted of 165-amino acids after cleavage. Despite several asparagine residues in the N-
terminal domain, none seems to be the consensus site of traditional glycosylation (Martin et 
al., 2003). The GKN1 gene encodes a small protein of 185 amino acids containing a N-
terminal signal peptide (Yoshikawa et al., 2000). The BRICHOS domain consists of about 100 
amino acids and it has been found in several unrelated proteins associated with major 
human diseases (Sanchez-Pulido et al., 2002) like BRI2, related to familial British and Danish 
dementia; chondromodulin-I (ChM-I), linked to chondrosarcoma; surfactant protein C (SP-
C), associated with respiratory distress syndrome; and gastrokine 1 (also known as CA11, 
AMP18 & foveolin) (Shiozaki et al., 2001; Martin et al., 2003), linked to gastric cancer 
(Sanchez-Pulido et al., 2002; Shiozaki et al., 2001). Evaluation of GKN1 expression at mRNA 
and protein level, by RT-PCR and immunhistochemistry (IHC), was found only in stomach, 
gastric antrum, but not in esophagus, duodenum, or intestine (Oien et al., 2004). 
2.3 Evaluation of GKN1 expression levels  
The evaluation of GKN1 expression in normal and malignant cells was performed according 
the following strategy. 
2.3.1 Patients enrolment and clinical characterization 
In this study a population of 28 patients with gastric cancer (20 intestinal and 8 diffuse 
types) was enrolled. Interview focusing on diet and lifestyle habits, family history and other 
toxic environmental factors was performed. A family history positive for gastric cancer was 
also carefully verified. The biopsy specimens were taken during an upper video-endoscopy 
in the gastric body or collected immediately after surgical resection and soon delivered for 
diagnosis and tissue sampling. Specimens were used for culture test, histological and 
immunohistochemical tests and for molecular approach. 
Gastric biopsy specimens were collected from normal subjects and patients with erosive 
gastritis, peptic ulcer or gastric cancer, either infected or not infected with H. pylori. None of 
the subjects had taken antibiotics, proton pump inhibitors or nonsteroidal antinflammatory 
drugs during the preceding 3 months. At least 65 gastric biopsy specimens were taken 
during upper endoscopy: one pinch was used to measure the urease activity (rapid urease 
test), and one pinch was used for a histological examination of H. pylori infection using 
hematoxylin-eosin stain. Three pinches and four pinches were used respectively for protein 
and RNA extraction. 36 patients (55%) showed to be negative for H. pylori infection and 
among these, 31 had normal mucosa while the remaining 5 had minimal infiltration of 
lymphomonocytes in the lamina propria. H. pylori infection was detected in 29/65 patients 
suffering from active gastritis (25 mild-moderate and 4 severe); 10 patients showed mild  
or moderate atrophy that was associated in 4 cases with focal antral complete IM.  
Anti-H. pylori and anti CagA IgG antibodies were not detected in any of the H. pylori-
negative subjects but were found in 29 (100%) and 21 (72%) H. pylori-positive patients, 
respectively. 
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2.3.2 Proteomic analysis 
In order to identify proteins differently expressed in human gastric mucosa without and 
with H. pylori infection, proteins extracted from biological specimens were analyzed by 2D 
electrophoresis in the pH range 3-10. Protein samples (100 μg) were focused on IPG strips 
and then separated by 12% SDS-PAGE. Proteins were stained with Comassie Brilliant Blue 
G-250. Comassie-stained protein spots were excised from 2-D gels and treated with 10 ng/μl 
of trypsin and digested overnight at 37°C according to Schevechencko et al., 1996. The 
peptide mixture obtained was then analyzed using a MALDI-TOF mass spectrometer 
Voyager DETM PRO (Applied Biosystems), operating in positive-ion reflectron mode. 
Protein identification was achieved using MALDI mass spectral data for a data-base search 
against the NCBInr database using the Mascot search algorithm, a parameter representing 
the reliability of protein identification (see also http://www.matrixscience.com/) (Nardone 
et al., 2007). 
Figure 1, shows the protein profiles observed in human gastric mucosa specimens. GKN1 
was identified by MALDI-TOF analysis of tryptic fragments (Rippa et al., 2007). On 2D gels, 
the GKN1 protein spot was found in all samples from H. pylori non-infected patients and it 
was generally drastically reduced in several samples of H. pylori infected tissues. The amino 
acid sequence of GKN1 isolated from gel covered about 38% of the entire protein sequence. 
Mature GKN1 did not contain the first 20 amino acid leader peptide as confirmed by the 
amino acid sequence of the N-terminal performed by Edman’s degradation. As expected 
from the isoelectric point of the mature protein (pI = 5.32), the migrating position of GKN1 
on the 2D gel was toward acidic pH. 
 
 
Fig. 1. Bidimensional gel electrophoresis of proteins extracted from gastric endoscopic 
mucosal samples. A) H. pylori-negative sample, B) H. pylori-positive sample. The first-
dimension (isoelectric focusing, IEF) was performed using the Ettan IPGphor (Amersham 
Biosciences) equipped with 7 cm strip holders. 
To analyze more quickly the expression levels of GKN1 in our collection of samples from 
patients with and without H. pylori infection (45 cases), we first tried to use mono-
dimensional SDS-PAGE followed by staining of the gel with comassie blue. Figure 2 shows 
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the position of the GKN1 stained band after electrophoresis at around 18 kDa however this 
approach resulted only qualitative and not quantitative.  
 
 
Fig. 2. Monodimensional gel electrophoresis of proteins extracted from gastric endoscopic 
mucosal samples. SDS-PAGE (14%) of proteins extracted from gastric endoscopic mucosal 
samples from H. pylori-negative patient (Lanes 1, 3, 5) and H. pylori-positive patient (Lanes 2, 
4, 6). M, size markers. 
2.3.3 Western blotting analysis of GKN1 expression 
To detect more precisely the GKN1 expression levels, we adopted the Western blot 
procedure using a specific anti-GKN1 antibody (Abnova) raised against the intact protein. 
The analysis was carried out starting from three biopsies. Specimens were mixed with 
proteases inhibitor (Roche), homogenized and equivalent amounts of protein (10 µg) were 
separated by electrophoresis on sodium dodecyl sulfate-12% polyacrylamide gels. After 
electrophoresis, the proteins were electroblotted to a nitrocellulose membrane (Immobilon 
PQS). GKN1 protein was identified using a specific rabbit polyclonal antibody (Abnova, 
diluted 1/50000). Visualization was obtained with an ECL kit (Pirce). 
As reported in Figure 3, the reduction in expression levels of GKN1 was not always 
observed in all patients with H. pylori associated gastritis but only in about 20% of samples. 
The evaluation has been based on the expression levels of β-tubulin. In all cases, the 
reduction of GKN1 levels was about two times that of non-infected samples. Densitometric 
evaluation of the bands showed a lower level in H. pylori-positive patients compared to the 
H. pylori-negative subjects (average: 0.19 ± 0.02 vs 0.44 ± 0.07, p < 0.005). This finding is in 
agreement to what observed also in another proteomic analysis regarding other 
proteins/enzymes differentially expressed by H. pylori infection (Baek et al., 2004).  
We also analyzed the expression of GKN1 in human specimens derived from patients with 
gastric cancer. With respect to the non-tumoral area, it was observed that GKN1 expression 
was consistently down regulated or absent in tumoral area (Nardone et al., 2008). The 28 
patients with Gastric Cancer (GC) (20 intestinal and 8 diffuse) showed the following 
characteristics: the intestinal type was well differentiated in 4, moderately differentiated in 8 
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Fig. 3. Western blot analysis of human gastric mucosa samples. About 10 μg of protein 
extracts from samples of gastric mucosa from non-infected patient (-) and patients with H. 
pylori infection (+) were separated on SDS-PAGE and blotted against commercial antibody 
anti-GKN1 (A) and anti-β-tubulin (B) (control).  
and poorly differentiated in the remaining 8 cases, while four were in the early stage and the 
remaining 16 in the advanced stage. Diffuse type GC was poorly differentiated and 
advanced in all cases. The non tumoural areas of intestinal type GC showed a variable 
degree of gastric atrophy with diffuse IM, instead, the peritumoural areas of diffuse type GC 
showed a variable degree of non-dysplastic inflammation. H. pylori infection was not 
revealed in all cases of tumoural areas. It is interesting to point out, however, that H. pylori 
infection was detected, in the peritumoral areas, in 6 cases (4 early and 2 advanced). Anti-H. 
pylori IgG antibodies were detected in 16/20 patients with intestinal histotype GC and in 6 
out of 8 with diffuse type GC. Anti-CagA antibodies were detectable in 17/28 cases (14 
intestinal and 3 diffuse histotype). Using Western blot (WB) analysis, GKN1 protein 
expression was not detected in any of the tumoural areas but was revealed instead in non-
tumoural areas (Fig. 4).  
 
 
Fig. 4 Western blot analysis of GKN1 expression in human gastric specimens. About 20 μg of 
protein extracts from samples tumoral area (T) and non-tumoral area (NT) were separated 
on SDS-PAGE and blotted against commercial antibody anti-GKN1 (A) and anti--β-actin  
(B) (control).  
2.3.4 Immunohistochemical analysis of GKN1 expression 
The Immunohistochemical evaluation of GKN1 on surgical specimens was performed on 7-
micron sections of frozen unfixed gastric tissues. The percentages of immunoreactive cells 
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was scored as follows: 0-5% = negative; 5-25% = low staining; 25-50% = moderate staining; 
>50% = intense staining. The results obtained, summarized in Fig. 5 showed the absence of 
GKN1 in tumor tissues (our actual collection of about 30 cases). In fact, the GKN1 staining 
was intense in normal gastric tissues, low or completely negative in intestinal metaplasia 
and gastric cancer, respectively (Fig. 5) (Rippa et al., unpublished results).  
 
 
 
Fig. 5. Representative immunohistochemical images of surgical specimens from: A) Normal 
gastric tissue (LSAB, orig. magn. X200); B) Intestinal metaplasia (LSAB, orig. magn. x100); C) 
Intestinal type gastric cancer (LSAB, orig. magn. X200). 
In addition, the hystopathological aspect of the tumor specimens correlated to the GKN1 
expression with tumor subtype. This observation suggested that GKN1 could play an 
important role in normal gastric function thus and strongly suggested that GKN1 could be a 
biomarker for gastric cancer (Yoshihara et al., 2006; Moss et al., 2008). 
3. Functional role of GKN1  
Regarding the functional role of GKN1, there are two questions that are still to be clarified. 
The first important question is whether GKN1 is secreted from gastric cells. Although data 
from bioinformatics analysis and the presence in the protein of a leader peptide sequence, 
there is not a conclusive answer to this point. If GKN1 is secreted from the gastric mucosa 
cells, other questions will raise up concerning the sequence of the secreted protein and how 
it interacts with its target cells. The second question is whether and how the GKN1 protein 
modulates the behavior of gastric cells. To this aim, we started to elucidate the role of the 
protein in the processes of proliferation and signalling transduction analyzing the 
expression of GKN1 in gastric carcinoma cells and its effects on apoptosis. 
3.1 Over-expression of GKN1 in gastric cancer cell lines 
The knowledge about the biological function of GKN1 is not completely clarified. What is 
known at the moment is that GKN1 appears to be important in maintaining mucosal 
integrity and could play a role in cell proliferation and differentiation. In fact, GKN1 might 
have a protective effect by increasing accumulation of specific tight and adherens junction 
proteins and also protecting their loss after injury (Walsh-Reitz et al., 2005). The presence in 
GKN1 of the BRICHOS domain might explain its protective role. In fact, the BRICHOS is 
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present also in another gastric protein GKN2, known also TFIZ1, because of its homology to 
GKN1. This protein is involved in the binding of tumor suppressor proteins such as the 
trefoil protein 1 (TFF1). Such interaction could be important in the regulation of the integrity 
of the mucosa (Bruce et al., 2005; Otto et al., 2006; Baus-Loncar et al., 2007).  
The strong down-regulation of GKN1 expression in patients with H. pylori infection 
(Nardone et al., 2007) its absence in gastric cancer (Nardone et al., 2008; Moss et al., 2008) 
and its absence in human gastric cancer cell lines (AGS and MKN28) (Motoyama et al., 1986; 
Segal et al., 1996; Oien et al., 2004) are factors that suggest the participation of GKN1 in the 
host response to H. pylori and suggest also that GNN1 can act as gastric tumor suppressor 
gene (Du et al., 2003). Regarding this point, since GKN1 is highly down-regulated or absent 
in gastric cancer, one possible explanation of its disappearance could be linked to epigenetic 
events or loss of heterozygosity, as it was observed for other tumor suppressor genes such 
as TFF1 (Carvalho et al., 2002). However, as recently reported by Yoon et al., 2010, no 
significative mutations nor methylation in the GKN1 gene in gastric tumors were found, 
thus the down-regulation of GKN1 it is likely not depending by epigenetic events. 
Toback et al., (2003) proposed that GKN1 could have some mitogenic effects on intestinal 
epithelial cells (IEC) as compared with EGF 5. Shiozaki et al., 2001, instead found that this 
protein was able to inhibit proliferation of a human carcinoma cancer cell line (MKN28) cells 
after transfection. From this finding it emerges that it is important to define the role of 
GKN1 in the modulation of inflammatory damage or tumorigenesis in the gastric mucosa. 
Attempts to reduce cancer survival rates include strategies directed towards the 
identification of specific targets inducing apoptosis in tumor cells. 
3.1.1 Evaluation of transient expression of GKN1 in gastric cancer cell 
AGS or MKN28 cancer cells (Motoyama, et al., 1986) were transfected with the eukaryotic 
expression vectors pcDNA 3.1 containing the entire GKN1 cDNA. Cells were grown in 5% 
CO2 at 37° in DMEM (Dulbecco’s modified Eagle’s medium) and transfected using 
lipophectamine 2000. After transfection, cell growth and apoptosis was evaluated by 
cytofluorimetry.  
The overexpression of GKN1 in MKN28 or AGS cells, with respect to control cells, reduced 
cell growth (Rippa et al., 2010). A similar effect was also reported by Shiozaki et al., 2001, 
who observed a reduction in MKN28 colony formation in cells transfected with CA11 gene 
with respect to control cells. Also GKN3, the new gastrokine found in mammals, strongly 
attenuated the growth of GKN3-overexpressing MKN28 cells (Menheniott et al., 2010). 
Because tissue repair is determined by many signals coming from the local environment, 
central to this process is the commitment of gastric cells to undergo apoptosis, survive, or 
proliferate, following inflammation. Therefore, gastric epithelial cell apoptosis could be 
influenced by GKN1 during the inflammatory process. The Fas-Fas ligand (FasL) system has 
been recognized as the major pathway for the induction of apoptosis in a variety of human 
normal and neoplastic cells (Itoh & Nagata, 1993; Suda et al., 1993; Nagata 1996). The Fas 
antigen (CD95, APO-1) belongs to a conserved family of membrane receptors known as the 
tumor necrosis factor receptor or TNFR family (Itoh et al., 1991). Therefore, overexpression 
of GKN1 could activate Fas, normally expressed at extremely low levels at least in MKN28 
cells (Osaki et al., 2001). In fact, the expression of Fas receptor, evaluated by flow cytometry 
(Figure 6) Western blotting and RT-PCR showed a significant increase. 
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Fig. 6. Flow cytometric analysis of apoptosis in AGS cells. Representative flow cytometry of 
cells transfected with empty pCDNA 3.1, lipophectamine and GKN1 before (A, B, C) and 
after (A1, B1, C1) incubation with a monoclonal antibody (IgM) anti-FasL.  
 
 
 
Fig. 7. Confocal microscopy of AGS cells. AGS cells were transfected with pCDNA 3.1 
containing the GKN1 cDNA and after 48 hours from transfection cells were analyzed at 
confocal microscopy in the presence of antibody anti-GKN1 and anti-Fas. A) Untransfected 
cells. B) Cells treated with lopophectamine. C) Non-premealized transfected cells after 
incubation with anti-GKN1 antibody. D) Premeabilized transfected cells after incubation 
with anti-GKN1 antibody. E) Non-premeabilized untransfected cells after incubation with 
anti-Fas antibody. F) Premeabilized transfected cells after incubation with anti-Fas antibody. 
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Fas expression was also analyzed by confocal microscopy. As shown in Fig. 7, compared to 
the control cells, cells treated with lipophectamine and cells transfected with GKN1 showed, 
exposure of the permeabilized transfected cells to anti-GKN1 antibody showed a gain in the 
fluorescent signal that indicated mainly a cytoplasmic distribution of GKN1 protein 
whereas, the exposure of the transfected cells to anti-Fas antibody showed with respect to 
untransfected cells a gain in the fluorescent signal that was localized mainly at the level of 
cell membrane. 
Therefore, the increase of Fas expression observed in cells transfected with GKN1 appeared 
to be specific as also demonstrated by the increase of the Fas mRNA transcription evaluated 
by RT-PCR (not shown). Fas-mediated apoptosis in gastric cells was also described upon 
infection by H. pylori, however in this case other apoptotic factors are involved as well. 
These include TRIAL and its receptor subtypes (Yang, et al. 2003; Martin et al., 2004). 
Because the binding of Fas ligand (FasL) to the Fas antigen results in the transduction of a 
cytolytic signal into the cell followed by apoptosis, cells overexpressing GKN1 showed an 
increase in apoptosis that is mainly due to the exposure of the MKN28 cells to FasL with 
respect to that observed in the absence of FasL. In addition, when FasL binds to Fas, 
intracellular death caspases are activated, resulting in apoptotic demise of the cell (Chen et 
al., 1999). Also in cells transfected with GKN1, we observed the proteolytic activation of 
caspase-3, normally present as a 32 kDa inactive precursor (Zou et al., 1997), as evaluated by 
Western blot and fluorimetric assay, was observed thus indicating that GKN1-transfected 
cells were signaled to die (Nicholson et al., 1995; Schlegel et al., 1996; Wang et al., 1996).  
 
 
 
 
 
Fig. 8. Western blot of caspase-3. Evaluation of caspase-3 activation in AGS cells before (A) 
and after (A) 48 h transfection with GKN1 and exposure to FasL.  
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In addition, Yoon et al., 2011, found that transfection of GKN1 in AGS cells showed 
activation of apoptosis related proteins, including cleaved caspase 3, caspase 8 and PARP. 
The GKN1-induced apoptosis is suppressed by the presence of caspase-3 and caspase-8 
inhibitors. 
4. Conclusion 
We have evaluated the expression of GKN1 in normal and unhealthy tissues and found that 
the GKN1, both at protein and mRNA levels, is down-regulated in human specimens from 
H. pylori infected gastric mucosa or absent in gastric GC tissues or cells. GKN1 is instead 
normally present in normal tissues and cells or in the peritumoral area of GC. Also the 
immunohistochemical analysis of human specimens (normal tissues, intestinal metaplasia, 
GC) showed a progressive decrease of GKN1 expression thus suggesting that GKN1 could 
be a good biomarker candidate for gastric cancer progression. 
In addition, our studies on the overexpression of the protein in gastric cancer cell lines 
showed that GKN1 could act as modulator of apoptosis and suggested a possible role of 
GKN1 as a tumor suppressor gene. The modulation of apoptotic signals by GKN1 during 
the early stages of acute gastric injury may have a profound influence on tissue repair and 
be instrumental in determining the individual host response. 
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